Frontiers

Frontline

DIRECT-TO-CONSUMBER GENOMICS: What should I do now, doctor? By Amy Sturm Clinical Assistant Professor Division of Human Genetics The Ohio State University Medical Center     It is difficult to watch television these days without seeing advert ...[Read more]
Published: Jan-13-10 | 3  Comments | 0  Link to this post

Breakthrough

TRANSLATIONAL TEAMWORK SPORE Grant Boosts Leukemia Research The National Cancer Institute (NCI) has awarded The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute a five-year, $11.5 million S ...[Read more]
Published: Jan-13-10 | 4  Comments | 0  Link to this post

Of Note – Recent recognitions of OSUCCC-James physicians and researchers

AWARDS AND RECOGNITIONS Richard Burry, director of the OSUCCC Microscopy shared resource and the Campus Microscopy and Imaging Facility, has received the Carpenter-Rasch Award from The Histochemical Society. Burry (standing left) was recognized ...[Read more]
Published: Jan-13-10 | 16  Comments | 0  Link to this post

Shedding New Light – HPV and oropharyngeal cancer

MAURA GILLISON, MD, PhD, Medical oncologist, head and neck cancer specialist and the Jeg Coughlin Chair in Cancer Research with her team (left to right). Hebin Song, MB, PhD; Tatevik Broutian, MS; Zhen-yue Tong, MD, PhD; Michael Koluder; Robert Pi ...[Read more]
Published: Jan-13-10 | 14  Comments | 0  Link to this post

Fractionating Forests – Discovering promising anitcancer agents requires experience and the science of pharmacognosy

Douglas Kinghorn, PhD, DSc, Jack Beal Professor and Chair of Natural Products Chemistry and Pharmacognosy in the College of Pharmacy By Darrell E. Ward photography by Roman Sapecki In August 2000, Drs. Soedarsono Riswan and Leonardus B.S. Kard ...[Read more]
Published: Jan-13-10 | 10  Comments | 0  Link to this post

The Right Collaboration – Improving the clinical outcome of CLL patients

John Byrd, MD, (left) professor of Internal Medicine, and The D. Warren Brown Designated Professor ship in Leukemia Research and co-leader of the OSUCCC Innate Immunity Program and Michael Grever, MD, (right) professor and chair of the Department ...[Read more]
Published: Jan-13-10 | 11  Comments | 0  Link to this post

Bench to Bedside

OSU 08173 – A Randomized, Double-Blind, Multi-Center, Phase III Study of Brivanib Plus Best Supportive Care versus Placebo Plus Best Supportive Care in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Failed or Are Intolerant to Sorafe ...[Read more]
Published: Jan-13-10 | 3  Comments | 0  Link to this post

Need to Know

BREAKING GROUND ProjectONE plan approved Architectural rendering of ProjectONE’s proposed 17-story tower that will house the new cancer hospital plus a critical care hospital and outpatient and support facilities. In September, The Ohio ...[Read more]
Published: Jan-13-10 | 14  Comments | 0  Link to this post